Search
Zerencotrep
go.drugbank.com/drugs/DB21710ExperimentalZerencotrep has a monoisotopic molecular weight of 524.11 Da. … Zerencotrep is a small molecule drug. The usage of the INN stem '-cotrep' in the name indicates that Zerencotrep is a transient receptor potential canonical channel 5 (TRPC5) antagonist.
Inlexisertib
go.drugbank.com/drugs/DB21713InvestigationalInlexisertib is a small molecule drug. The usage of the INN stem '-sertib' in the name indicates that Inlexisertib is a serine/threonine kinase inhibitor. … Inlexisertib has a monoisotopic molecular weight of 535.29 Da.
Lecufexor
go.drugbank.com/drugs/DB21714ExperimentalLecufexor is a small molecule drug. Lecufexor has a monoisotopic molecular weight of 618.05 Da.
Matsupexole
go.drugbank.com/drugs/DB21715ExperimentalMatsupexole is a small molecule drug. Matsupexole has a monoisotopic molecular weight of 446.25 Da.
Balinatunfib
go.drugbank.com/drugs/DB21728InvestigationalBalinatunfib is a small molecule drug. Balinatunfib has a monoisotopic molecular weight of 502.19 Da.
Cenacitinib
go.drugbank.com/drugs/DB21735InvestigationalCenacitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Cenacitinib is a Janus kinase inhibitor. … Cenacitinib has a monoisotopic molecular weight of 431.15 Da.
Certociclib
go.drugbank.com/drugs/DB21736InvestigationalCertociclib has a monoisotopic molecular weight of 365.14 Da. … Certociclib is a small molecule drug. Certociclib is under investigation in clinical trial NCT05252416 ((VELA) Study of BLU-222 in Advanced Solid Tumors).
Rogocekib
go.drugbank.com/drugs/DB21739InvestigationalRogocekib is a small molecule drug. Rogocekib has a monoisotopic molecular weight of 408.15 Da.
PRO-1562
go.drugbank.com/drugs/DB33979ExperimentalPRO-1562 is a small molecule drug. … PRO-1562 is under investigation in clinical trial NCT07826689 (A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients With Relapsing Multiple Sclerosis).
SHR-1179
go.drugbank.com/drugs/DB33981ExperimentalSHR-1179 is a small molecule drug. … SHR-1179 is under investigation in clinical trial NCT07826364 (A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Study of SHR-1179 Injection in Participants With Obesity).